NCT05207202

Brief Summary

Acute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lung injury. Positive end-expiratory pressure (PEEP), as one of main component of MV, has been widely used in the clinical practice. However, the PEEP selection is still a difficult problem for moderate to severe ARDS patients. EIT, an imaging tool evaluating the regional ventilation distribution at the bedside, can achieve the individual PEEP selection for all mechanically ventilated patients. This article compared the effect of PEEP titrated guided by EIT with fraction of inspired oxygen (FiO2)-PEEP table on the clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
190

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 26, 2022

Completed
25 days until next milestone

Study Start

First participant enrolled

February 20, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2023

Completed
Last Updated

March 20, 2025

Status Verified

March 1, 2025

Enrollment Period

1.4 years

First QC Date

December 15, 2021

Last Update Submit

March 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • 28-day mortality

    mortality in Day 28

    at day 28

Secondary Outcomes (12)

  • VFDs at day 28

    at day 28

  • Shock-free days at day 28

    at day 28

  • Length of ICU stay

    up to 24 months

  • Length of hospital stay

    up to 24 months

  • The rate of successful weaning

    at day 28

  • +7 more secondary outcomes

Other Outcomes (3)

  • blood gas

    28 day

  • vital signs

    28 day

  • Ventilator parameters and respiratory mechanics

    28 day

Study Arms (2)

EIT-PEEP strategy

ACTIVE COMPARATOR

Patients will receive PEEP titrated by EIT with a stepwise decrease PEEP trial

Device: electrical impedance tomography

ARDSNet-PEEP strategy

ACTIVE COMPARATOR

PEEP will be set according to the low FiO2-PEEP table to keep the oxygenation goals: SpO2 between 88% and 95%, and PaO2 between 55mmHg and 80mmHg.

Device: electrical impedance tomography

Interventions

PEEP titrated by EIT will be performed with a decremental trial at the enrollment. Right after completing RM, PEEP will be set to 20cmH2O and then reduced in steps of 2cmH2O from 20 to zero every 2min.

ARDSNet-PEEP strategyEIT-PEEP strategy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age≥18 years
  • Moderate-to-severe ARDS, defined by the ARDS Definition Task Force in the Berlin definition (partial pressure of arterial oxygen \[PaO2\]:FiO2 ratio ≤200 mmHg with a PEEP ≥5 cmH2O)
  • Diagnosis of ARDS less than 72 hours

You may not qualify if:

  • Expected to be mechanically ventilated for less than 48 hours
  • Severe chronic respiratory diseases requiring long-term home oxygen therapy or noninvasive MV
  • Undrained pneumothorax or subcutaneous emphysema
  • Undergoing extracorporeal membrane oxygenation (ECMO) before enrollment
  • Contraindication to the use of EIT (pacemaker, automatic implantable cardioverter defibrillator, and implantable pumps)
  • Severe neuromuscular disease
  • Hemodynamic instability
  • Contraindications to hypercapnia, such as intracranial hypertension or acute coronary syndrome
  • Severe other organs dysfunction with a low expected survival (7 days) or palliative care
  • Solid organ or hematologic tumors with the expected survival time less than 30 days
  • Participating in other clinical trials within 30 days
  • Pregnancy
  • Refusal to sign the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

the First Affiliated Hospital of Guangzhou Medical University, Department of Critical Care Medicine

Guangzhou, Guangdong, sonysang999@aliyun.com, China

Location

Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University

Nanjing, Jiangsu, 210000, China

Location

Department of Critical Care Medicine, Renji Hospital

Shanghai, Shanghai Municipality, 200120, China

Location

Department of Critical Care Medicine, Zhongshan Hospital of Fudan University

Shangha, Shangha, 200032, China

Location

Department of ICU, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital

Chengdu, Sichuan, 610072, China

Location

Related Publications (1)

  • Yuan X, Zhang R, Wang Y, Chen D, Chao Y, Xu J, Guo L, Liu A, Xie J, Pan C, Yang Y, Qiu H, Liu L. Effect of EIT-guided PEEP titration on prognosis of patients with moderate to severe ARDS: study protocol for a multicenter randomized controlled trial. Trials. 2023 Apr 11;24(1):266. doi: 10.1186/s13063-023-07280-6.

Study Officials

  • ling liu, phD

    Southeast University, China

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Intensive Care Unit, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

December 15, 2021

First Posted

January 26, 2022

Study Start

February 20, 2022

Primary Completion

July 20, 2023

Study Completion

July 20, 2023

Last Updated

March 20, 2025

Record last verified: 2025-03

Locations